PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 91 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 42.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $356,000 | +21.1% | 68,940 | -10.1% | 0.00% | – |
| Q2 2021 | $294,000 | +40.7% | 76,683 | -5.9% | 0.00% | – |
| Q1 2021 | $209,000 | -7.9% | 81,471 | -10.5% | 0.00% | – |
| Q4 2020 | $227,000 | +39.3% | 90,995 | +15.2% | 0.00% | – |
| Q3 2020 | $163,000 | -35.6% | 78,967 | -3.3% | 0.00% | – |
| Q2 2020 | $253,000 | +44.6% | 81,702 | +6.5% | 0.00% | – |
| Q1 2020 | $175,000 | +173.4% | 76,741 | +304.1% | 0.00% | – |
| Q3 2019 | $64,000 | +52.4% | 18,989 | +49.5% | 0.00% | – |
| Q1 2019 | $42,000 | -39.1% | 12,701 | -7.2% | 0.00% | – |
| Q2 2018 | $69,000 | -34.9% | 13,687 | -12.2% | 0.00% | – |
| Q1 2018 | $106,000 | +37.7% | 15,585 | +53.1% | 0.00% | – |
| Q4 2017 | $77,000 | -42.1% | 10,181 | -56.0% | 0.00% | – |
| Q3 2017 | $133,000 | +146.3% | 23,140 | +120.5% | 0.00% | – |
| Q2 2017 | $54,000 | – | 10,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,196,527 | $16,526,000 | 3.00% |
| BVF INC/IL | 5,328,239 | $27,547,000 | 1.08% |
| Soleus Capital Management, L.P. | 740,000 | $3,826,000 | 0.60% |
| Cutter & CO Brokerage, Inc. | 326,100 | $1,686,000 | 0.40% |
| EAM Investors, LLC | 288,459 | $1,491,000 | 0.25% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $5,316,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,551,000 | 0.11% |
| Navis Wealth Advisors, LLC | 16,000 | $83,000 | 0.06% |
| Sigma Planning Corp | 364,484 | $1,884,000 | 0.06% |
| XTX Topco Ltd | 32,650 | $169,000 | 0.06% |